BackAllergy Therapeutics plc Overview

Allergy Therapeutics plc Current Cash

Track Allergy Therapeutics plc's current cash ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$10.08M
↓ 53.48% YoYΔ $-11.59M vs prior year quarter

Peer trimmed avg / median

Loading

Allergy Therapeutics plc Current Cash History

Loading

Allergy Therapeutics plc vs. peers: Current Cash Comparison

Loading

Allergy Therapeutics plc Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Allergy Therapeutics plc (AGYTF) FAQ

As of the most recent data (December 2025), AGYTF shows a current cash of $10M. That compares with $22M in the prior-year period — down 53.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AGYTF's current cash is now $10M (was $22M) — a 53.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Allergy Therapeutics plc is outperforming or lagging.

Tracking AGYTF's current cash over time shows whether Allergy Therapeutics plc is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $22M in the prior-year period — down 53.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Allergy Therapeutics plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $10M) with ownership activity and broader fundamentals.